How can outsourcing buffer preparation help meet the world's urgent need for a SARS-CoV-2 vaccine?

As the SARS-CoV-2 crisis maintains its grip on the world, the pressure to develop and distribute effective treatments and vaccines continues to mount. To meet the worldwide demand, drug companies will have to scale up their manufacturing capabilities dramatically. In this planning, buffers must be taken into account. These solutions are indispensable for drug development and manufacturing processes and outsourcing can be essential to increasing manufacturing capacity and speed.

This whitepaper explores the decisions and economics behind outsourcing buffer preparation.

Complete the short form below to download the full white paper.